Business Description
Medline Inc
NAICS : 325414
SIC : 3841
ISIN : US58507V1070
Share Class Description:
FRA:L10: Ordinary Shares - Class ATotal Employee Number:
45,000Description
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.12 | |||||
Debt-to-EBITDA | 4.23 | |||||
Interest Coverage | 2.69 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 2.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44 | |||||
3-Year EBITDA Growth Rate | 56.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.22 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.22 | |||||
9-Day RSI | 53.81 | |||||
14-Day RSI | 53.02 | |||||
3-1 Month Momentum % | -14.66 | |||||
6-1 Month Momentum % | -14.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.41 | |||||
Quick Ratio | 2.51 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 80.21 | |||||
Days Sales Outstanding | 43.75 | |||||
Days Payable | 16.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 11.45 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.86 | |||||
Operating Margin % | 7.08 | |||||
Net Margin % | 3.32 | |||||
EBITDA Margin % | 10.25 | |||||
FCF Margin % | 3.52 | |||||
OCF Margin % | 5.05 | |||||
ROE % | 17.36 | |||||
ROA % | 2.56 | |||||
ROIC % | 5.32 | |||||
ROC (Joel Greenblatt) % | 17.83 | |||||
ROCE % | 5.59 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.61 | |||||
Forward PE Ratio | 25.3 | |||||
PE Ratio without NRI | 41.26 | |||||
PS Ratio | 1.31 | |||||
PB Ratio | 3.04 | |||||
Price-to-Free-Cash-Flow | 45.17 | |||||
Price-to-Operating-Cash-Flow | 29.47 | |||||
EV-to-EBIT | 26.8 | |||||
EV-to-Forward-EBIT | 17.36 | |||||
EV-to-EBITDA | 17.66 | |||||
EV-to-Forward-EBITDA | 12.38 | |||||
EV-to-Revenue | 1.81 | |||||
EV-to-Forward-Revenue | 1.44 | |||||
EV-to-FCF | 51.26 | |||||
Earnings Yield (Greenblatt) % | 3.73 | |||||
FCF Yield % | 3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medline Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 25,041.72 | ||
| EPS (TTM) (€) | 0.64 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 53.02 | ||
| 14-Day ATR (€) | 0.845172 | ||
| 20-Day SMA (€) | 34.58 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 27.8 - 42.6 | ||
| Shares Outstanding (Mil) | 845.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medline Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medline Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-08-05 09:30 | In 8 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 7 days | ||
| General meeting for 2026 | 2026-06-11 10:00 | 30.40 (+0.00%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 10:40 | 28.40 (+0.00%) | ||
| William Blair 46th Annual Growth Stock Conference | 2026-06-03 15:40 | 30.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 09:30 | 37.40 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 37.40 (+0.00%) | ||
| Barclays 28th Annual Global Healthcare Conference | 2026-03-11 09:30 | 36.60 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-25 09:30 | 41.80 (+0.00%) | ||
| Annual report for 2025 | 2026-02-25 | 41.80 (+0.00%) |
Show
Entries
Medline Inc Frequently Asked Questions
What is Medline Inc(FRA:L10)'s stock price today?
The current price of FRA:L10 is €34.20. The 52 week high of FRA:L10 is €42.60 and 52 week low is €27.80.
When is next earnings date of Medline Inc(FRA:L10)?
The next earnings date of Medline Inc(FRA:L10) is 2026-08-05.
Does Medline Inc(FRA:L10) pay dividends? If so, how much?
Medline Inc(FRA:L10) does not pay dividend.
Press Release
Articles on Medline Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers